BCM
MIST icon

Boxer Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

Boxer Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$793K Hold
666,666
– – 0.1% 50
2025
Q4 		$1.35M Hold
666,666
– – 0.29% 40
2025
Q3 		$1.33M Buy
+666,666
New +$1.17M 0.43% 28
2025
Q1 		– Sell
-309,007
Closed -$729K – 44
2024
Q4 		$729K Buy
+309,007
New +$530K 0.06% 55

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Boxer Capital Management's MIST Position: Q1 2026 in Review

Boxer Capital Management held its Milestone Pharmaceuticals (MIST) position steady in Q1 2026 at 666,666 shares worth $793K. The position accounts for 0.1% of the portfolio, ranked #50.

Boxer Capital Management first reported a position in MIST in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.35M in Q4 2025. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Boxer Capital Management held 666,666 shares of Milestone Pharmaceuticals worth $793K as of Q1 2026.
  • Boxer Capital Management left its Milestone Pharmaceuticals share count unchanged in Q1 2026.
  • Milestone Pharmaceuticals made up 0.1% of Boxer Capital Management's portfolio in Q1 2026, its #50 holding.
  • Boxer Capital Management first reported a position in Milestone Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Boxer Capital Management's Milestone Pharmaceuticals position peaked at $1.35M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Boxer Capital Management's 13F filing for Q1 2026, filed 15 May 2026.